Ionis Pharmaceuticals: Q1 Earnings Snapshot

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Tuesday reported a loss of $143 million in its first quarter.

The Carlsbad, California-based company said it had a loss of 98 cents per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

The drug discovery and development company posted revenue of $119 million in the period, falling short of Street forecasts. Seven analysts surveyed by Zacks expected $131.5 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on IONS at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up